News & Press Releases Swedish

Scandinavian ChemoTechs TSE teknologi ger hopp till hästar som lider av sarkoider

Idag öppnade ESVONC kongressen i Syrakusa, Italien. I en poster som presenteras vid kongressen presenteras behandlingen av en häst där resultatet beskrivs som enastående.

Read more

Kommuniké från årsstämma i Scandinavian ChemoTech AB (publ) den 24 maj 2022

Scandinavian ChemoTech AB (publ) (”Bolaget”) höll den 24 maj 2022 årsstämma. Vid stämman fattades följande beslut:

Read more

Scandinavian ChemoTech erhåller slutligt patentgodkännande i EU för den tumörspecifika kontrollenheten i vår TSE™-plattform

Företaget har fått det slutgiltiga godkännandet för sitt EU-patent som inkluderar den tumörspecifika kontrollenheten och säkerhetsfunktioner som är avgörande för vår TSE-plattform. Innovationen är utformad för att minska de biverkningar som normalt uppstår med äldre elektroporations- och ablativa tekniker.

Read more

News & Press Releases English

Scandinavian ChemoTech’s TSE technology gives hope to horses suffering from sarcoids

Today the ESVONC congress in Syracuse, Italy, opens. In a poster, presented at the congress, the Tumour Specific Electroporation - TSE™ treatment of a horse is outlined and described as showing outstanding results.

Read more

Scandinavian ChemoTech receives final patent approval in the EU for the tumour specific control unit in our TSE™ platform

The Company has received the final approval for its EU patent which includes the tumour specific control unit and safety features that are crucial for our TSE platform. The innovation is designed to reduce the side effects which normally occur with older electroporation and ablative technologies.

Read more

Scandinavian ChemoTech's subsidiary Vetiqure participates in ESVONC's congress in Italy

Between May 26–28th 2022, our product specialist Elin Wallin and our CEO Mohan Frick will participate in ESVONC's annual congress in Italy. A poster on treatment with our TSE™ technology has been accepted and will also be presented there.

Read more

ChemoTech Videos

2022

SWECARE at EXPO 2020 DUBAI: "Closing Ceremony"

A conversation with Småbolagspodden

(Audio in Swedish)

I det senaste avsnittet av Småbolagspodden berättar Scandinavian ChemoTechs vd Mohan Frick om hur bolagets unika metod för cancerbehandling, via så kallad tumörspecifik elektroporation, ska hjälpa människor och djur världen över.

Lyssna på hela avsnittet här:
52. ChemoTech – Vill vara en kraft för skonsammare cancervård

2021

Presentation of Q3 - Analysera med oss November 2021 (Swedish)

ChemoTech presents for its upcoming Annual General meeting 24 May 2021. Spoken language is Swedish but the presentation is in English.

Innovative TSE technology increases the local effect of chemotherapy (Swedish)

ChemoTech answers questions from the shareholders; Part 1 (Swedish)

CEO Mohan Frick presenting at Erik Penser Bank Bolagsdag (Swedish)

Erik Penser Bank interview with CEO Mohan Frick (Swedish) 8 January 2021

Videos from 2020

Company Presentation of the Q3 report (Swedish) 11th of November 2020

Company Presentation (Swedish) 27th of October 2020

Videos from 2019

Share Day in Gothenburg, November 4 2019 (Swedish)

Videos from 2018

Share analysis ChemoTech Q2 2018 (Swedish)

Share Day in Malmö on May 22, 2018 (Swedish)

Our foundation

Our profound knowledge in electroporation forms the starting point for the company’s existing product and R&D projects: The IQwave™ specially designed for our TSE™ – Tumour Specific Electroporation technology which treats a range of various tumours.

Our research focus

Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.